Peer-reviewed veterinary case report
Topical treatment with NexGardCombo helps cats with lung capillariosis
By Di Cesare, Angela et al.·Published in Parasite (Paris, France)·2024·Department of Veterinary Medicine, Italy·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Efficacy of a topical formulation containing eprinomectin, esafoxolaner and praziquantel (NexGardCombo) in the treatment of natural respiratory capillariosis of cats.
- Species:
- cat
Plain-English summary
A group of cats with respiratory issues caused by a parasite called Eucoleus aerophilus were treated with a topical solution called NexGardCombo, which contains eprinomectin, esafoxolaner, and praziquantel. After two doses given 28 days apart, the treatment was highly effective, reducing the number of parasite eggs in their feces by nearly 100% and significantly improving their breathing problems, coughing, and other symptoms. The cats showed no serious side effects, and the treatment helped them recover well.
People also search for: cat respiratory problems treatment · NexGardCombo for cats · cat coughing and sneezing · Eucoleus aerophilus in cats
Abstract
Feline pulmonary capillariosis is a significant disorder due to its distribution and clinical impact. This study evaluated the safety and efficacy of two administrations 28 days apart of a topical solution containing esafoxolaner, eprinomectin and praziquantel (NexGardCombo) in treating Eucoleus aerophilus (syn. Capillaria aerophila) infection in naturally infected cats. Cats were allocated to two groups: G1 cats (n = 23) received two treatments at study days (SDs) 0 and 28 (±2) and were evaluated for 6 weeks, and G2 cats (n = 17) served as a negative control for 6 weeks and were then treated twice on SDs 42 (±2) and 70 (±2), allowing for an additional 6-week assessment of efficacy. Each cat was subjected to McMaster coproscopy at SDs -7/0, 28 (±2) and 42 (±2) for both groups, 70 (±2) and 84 (±2) only for G2. Clinical examination and chest radiographic images were performed at SDs 0, 28 (±2) and 42 (±2) for G1 and G2, 70 (±2) and 84 (±2) only for G2. The comparison of EPG (eggs per gram of feces), clinical (CS), and radiographic scores (RS) at each time-point was used as a criterion. The efficacy based on the EPG reduction was 99.5% (G1) and 100% (G2) after two administrations of NexGardCombo 2 weeks apart. At SD 0, no significant differences for CS and RS were recorded between G1 and G2, while a significant reduction (p < 0.05) was observed post-treatment for CS, RS, oculo-nasal discharge, auscultation noises, and cough. Two doses of NexGardCombo 28 days apart stopped egg shedding and significantly improved clinical alterations in cats infected by E. aerophilus.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/38315065/